NORD: SHARE CAPITAL INCREASE REGISTERED
(Thomson Reuters ONE) - Reference is made to the stock exchange notice dated 18 January 2010 regardingthe final result in the subsequent offering in NorDiag ASA. The share capitalincrease of NOK 8,000,000 has now been registered with the Norwegian Register ofBusiness Enterprises (Nw.: Foretaksregisteret). As a consequence, the newregistered share capital of NorDiag is NOK 62,065,282, divided into 62,065,282shares, each with a par value of NOK 1.00.The new shares in NorDiag are registered in the Norwegian Central SecuritiesDepository (VPS) and are listed on Oslo B?today.Contact: CFO Tone Kv? Phone: +47 915 19576About NorDiag:NorDiag is a biotechnology company developing, manufacturing and marketingautomated solutions (instruments and tests) for sample preparation of DNA fromdifficult biological samples. DNA diagnostics give more rapid and preciseanswers, and is the fastest growing field within diagnostics. The company'ssample preparation solutions are today used in connection with STI,tuberculosis, MRSA, respiratory pathogens and viruses on instruments for largeand small laboratories. NorDiag was founded in 2003 and has its headquarters inOslo, Norway. The company has offices and laboratories in Stockholm, Sweden, inWest Chester (PA), USA and in Vienna, Austria. The group has today 40.1man-labour years. NorDiag is listed on Oslo Stock Exchange with ticker NORD.For further information, please seewww.nordiag.com
Unternehmensinformation / Kurzprofil:
Datum: 26.01.2010 - 12:49 Uhr
Sprache: Deutsch
News-ID 11549
Anzahl Zeichen: 0
contact information:
Town:
Bergen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 170 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"NORD: SHARE CAPITAL INCREASE REGISTERED"
steht unter der journalistisch-redaktionellen Verantwortung von
NorDiag ASA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
